LIDOCAINE HCI AND DEXTROSE 5 g/100mL
LIDOCAINE HCI AND DEXTROSE · INJECTION, SOLUTION · HF Acquisition Co LLC, DBA HealthFirst
LIDOCAINE HCI AND DEXTROSE is a injection, solution containing lidocaine hci and dextrose at 5 g/100mL, taken intravenous. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.
Key Facts
- Brand Name
- LIDOCAINE HCI AND DEXTROSE
- Generic Name
- LIDOCAINE HCI AND DEXTROSE
- NDC Code (Product)
51662-1565- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Strength
- 5 g/100mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA019830
- Marketing Start
- 07/17/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is LIDOCAINE HCI AND DEXTROSE used for?
LIDOCAINE HCI AND DEXTROSE contains LIDOCAINE HCI AND DEXTROSE. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is LIDOCAINE HCI AND DEXTROSE a controlled substance?
LIDOCAINE HCI AND DEXTROSE is not classified as a controlled substance by the DEA.
What is the generic name for LIDOCAINE HCI AND DEXTROSE?
The generic name for LIDOCAINE HCI AND DEXTROSE is LIDOCAINE HCI AND DEXTROSE. There are no other listed brand versions of LIDOCAINE HCI AND DEXTROSE.
What is the NDC code for LIDOCAINE HCI AND DEXTROSE 5 g/100mL?
The NDC (National Drug Code) for LIDOCAINE HCI AND DEXTROSE 5 g/100mL is 51662-1565, listed by HF Acquisition Co LLC, DBA HealthFirst.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)